☰

Damith G. Udugamasooriya, Ph.D. - Publications

Affiliations: 
2006 Wayne State University, Detroit, MI, United States 
Area:
Biochemistry, Biomedical Engineering, Pharmaceutical Chemistry
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kedika SR, Udugamasooriya DG. Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase. Organic & Biomolecular Chemistry. 16: 6443-6449. PMID 30140808 DOI: 10.1039/c8ob01406j  0.462
2017 Shukla SP, Udugamasooriya DG. A mini-library system to investigate non-essential residues of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1. Medchemcomm. 8: 2208-2215. PMID 29527284 DOI: 10.1039/C7MD00372B  0.365
2017 Shukla SP, Manarang JC, Udugamasooriya DG. A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1. European Journal of Medicinal Chemistry. 137: 1-10. PMID 28551176 DOI: 10.1016/j.ejmech.2017.05.040  0.46
2017 Desai TJ, Udugamasooriya DG. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1. Biochemical and Biophysical Research Communications. PMID 28322795 DOI: 10.1016/j.bbrc.2017.03.083  0.317
2016 Singh J, Shukla SP, Desai TJ, Udugamasooriya DG. Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1. Bioorganic & Medicinal Chemistry. PMID 27485601 DOI: 10.1016/j.bmc.2016.07.045  0.342
2012 Udugamasooriya DG, Kodadek T. On-Bead Two-Color (OBTC) Cell Screen for Direct Identification of Highly Selective Cell Surface Receptor Ligands. Current Protocols in Chemical Biology. 4: 35-48. PMID 22582145 DOI: 10.1002/9780470559277.Ch110199  0.348
2010 Rubini C, Ruzza P, Spaller MR, Siligardi G, Hussain R, Udugamasooriya DG, Bellanda M, Mammi S, Borgogno A, Calderan A, Cesaro L, Brunati AM, Donella-Deana A. Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies. Biopolymers. 94: 298-306. PMID 19921743 DOI: 10.1002/bip.21350  0.657
2009 Muders MH, Vohra PK, Dutta SK, Wang E, Ikeda Y, Wang L, Udugamasooriya DG, Memic A, Rupasinghe CN, Rupashinghe CN, Baretton GB, Aust DE, Langer S, Datta K, Simons M, et al. Targeting GIPC/synectin in pancreatic cancer inhibits tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4095-103. PMID 19509165 DOI: 10.1158/1078-0432.Ccr-08-2837  0.544
2008 Udugamasooriya DG, Sharma SC, Spaller MR. A chemical library approach to organic-modified peptide ligands for PDZ domain proteins: a synthetic, thermodynamic and structural investigation. Chembiochem : a European Journal of Chemical Biology. 9: 1587-9. PMID 18506876 DOI: 10.1002/Cbic.200800126  0.571
2008 Udugamasooriya DG, Ritchie C, Brekken RA, Kodadek T. A peptoid antagonist of VEGF Receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site Bioorganic and Medicinal Chemistry. 16: 6338-6343. PMID 18501615 DOI: 10.1016/J.Bmc.2008.05.015  0.396
2008 Udugamasooriya DG, Dineen SP, Brekken RA, Kodadek T. A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity Journal of the American Chemical Society. 130: 5744-5752. PMID 18386897 DOI: 10.1021/Ja711193X  0.37
2008 Udugamasooriya DG, Spaller MR. Conformational constraint in protein ligand design and the inconsistency of binding entropy. Biopolymers. 89: 653-67. PMID 18335423 DOI: 10.1002/bip.20983  0.636
Show low-probability matches.